Northern Trust Corp Aim Immuno Tech Inc. Transaction History
Northern Trust Corp
- $572 Billion
- Q1 2024
A detailed history of Northern Trust Corp transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Northern Trust Corp holds 85,206 shares of AIM stock, worth $38,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,206
Previous 85,566
0.42%
Holding current value
$38,342
Previous $37,000
8.11%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AIM
# of Institutions
35Shares Held
4.09MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$894,9160.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$314,2490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA352KShares$158,2450.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$99,3630.0% of portfolio
-
State Street Corp Boston, MA173KShares$77,8960.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $21.6M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...